Biotechnology
The Biotechnology industry has a total of 665 stocks, with a combined market cap of $865.29 billion and total revenue of $94.45 billion.
Market Cap
865.29B
Revenue
94.45B
Profits
-43.36B
PE Ratio
n/a
Profit Margin
-45.91%
Dividend Yield
0.01%
665 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 116.20B | 0.72% | 1,642,030 | 10.63B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.98B | -0.17% | 651,755 | 13.85B |
| 3 | ARGX | argenx SE | 35.14B | 3.01% | 367,393 | 1.91B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 32.09B | 6.20% | 1,032,147 | 2.09B |
| 5 | BNTX | BioNTech SE | 24.49B | -4.00% | 1,121,013 | 3.39B |
| 6 | BGNE | BeiGene, Ltd. | 20.64B | 3.46% | 261,610 | 3.35B |
| 7 | UTHR | United Therapeutics Corporation | 16.27B | 1.00% | 176,828 | 2.76B |
| 8 | RPRX | Royalty Pharma plc | 15.45B | 0.81% | 2,003,544 | 2.27B |
| 9 | MRNA | Moderna, Inc. | 14.22B | -0.94% | 7,279,167 | 5.08B |
| 10 | SMMT | Summit Therapeutics Inc. | 13.73B | -6.90% | 1,769,691 | - |
| 11 | INCY | Incyte Corporation | 13.69B | 0.69% | 2,137,082 | 4.08B |
| 12 | INSM | Insmed Incorporated | 13.00B | -1.42% | 1,675,803 | 342.96M |
| 13 | GMAB | Genmab A/S | 12.93B | -0.24% | 1,091,355 | 2.97B |
| 14 | BMRN | BioMarin Pharmaceutical Inc. | 11.92B | 0.95% | 1,142,877 | 2.75B |
| 15 | TECH | Bio-Techne Corporation | 10.92B | 3.54% | 1,456,655 | 1.17B |
| 16 | PCVX | Vaxcyte, Inc. | 10.71B | -1.29% | 1,675,438 | - |
| 17 | SRPT | Sarepta Therapeutics, Inc. | 10.59B | 3.98% | 1,112,538 | 1.64B |
| 18 | EXEL | Exelixis, Inc. | 9.90B | 0.70% | 1,681,603 | 2.08B |
| 19 | RVMD | Revolution Medicines, Inc. | 9.60B | 1.06% | 818,875 | 742.00K |
| 20 | ROIV | Roivant Sciences Ltd. | 8.36B | 1.59% | 2,902,848 | 129.13M |
| 21 | ASND | Ascendis Pharma A/S | 7.43B | -0.05% | 303,609 | 365.19M |
| 22 | LEGN | Legend Biotech Corporation | 7.36B | 4.53% | 2,232,762 | 520.18M |
| 23 | JAZZ | Jazz Pharmaceuticals plc | 7.21B | 2.07% | 401,630 | 3.99B |
| 24 | MDGL | Madrigal Pharmaceuticals, Inc. | 6.92B | 0.93% | 270,950 | 76.81M |
| 25 | NUVL | Nuvalent, Inc. | 6.48B | 0.12% | 255,130 | - |
| 26 | BPMC | Blueprint Medicines Corporation | 6.02B | 0.22% | 543,577 | 434.42M |
| 27 | CYTK | Cytokinetics, Incorporated | 5.88B | -2.41% | 1,063,082 | 3.22M |
| 28 | CORT | Corcept Therapeutics Incorporated | 5.88B | 3.29% | 933,118 | 628.56M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 5.82B | 2.12% | 1,814,631 | 947.36M |
| 30 | VKTX | Viking Therapeutics, Inc. | 5.74B | 0.04% | 3,479,409 | - |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 5.59B | 4.89% | 2,137,690 | 803.07M |
| 32 | RNA | Avidity Biosciences, Inc. | 5.21B | 0.92% | 655,142 | 10.12M |
| 33 | CRNX | Crinetics Pharmaceuticals, Inc. | 5.20B | 1.63% | 463,927 | 1.04M |
| 34 | KRYS | Krystal Biotech, Inc. | 5.12B | 0.14% | 180,349 | 241.52M |
| 35 | ADMA | ADMA Biologics, Inc. | 5.05B | 3.59% | 2,097,922 | 382.81M |
| 36 | BHVN | Biohaven Ltd. | 4.74B | 1.14% | 738,240 | - |
| 37 | ACLX | Arcellx, Inc. | 4.72B | -0.42% | 332,625 | 155.82M |
| 38 | AXSM | Axsome Therapeutics, Inc. | 4.58B | -0.90% | 362,363 | 338.46M |
| 39 | TGTX | TG Therapeutics, Inc. | 4.47B | 2.74% | 2,176,723 | 264.79M |
| 40 | BBIO | BridgeBio Pharma, Inc. | 4.35B | 2.22% | 1,362,600 | 217.77M |
| 41 | RARE | Ultragenyx Pharmaceutical Inc. | 4.28B | 2.81% | 633,419 | 522.75M |
| 42 | CRSP | CRISPR Therapeutics AG | 4.03B | 0.62% | 1,943,413 | 202.83M |
| 43 | IMVT | Immunovant, Inc. | 3.84B | 3.77% | 973,321 | - |
| 44 | RYTM | Rhythm Pharmaceuticals, Inc. | 3.65B | -1.02% | 370,513 | 112.53M |
| 45 | DNLI | Denali Therapeutics Inc. | 3.51B | 0.33% | 767,094 | - |
| 46 | APLS | Apellis Pharmaceuticals, Inc. | 3.42B | -5.17% | 3,302,328 | 715.22M |
| 47 | IBRX | ImmunityBio, Inc. | 3.40B | -8.88% | 5,011,804 | 7.33M |
| 48 | PTCT | PTC Therapeutics, Inc. | 3.24B | 6.61% | 693,010 | 900.66M |
| 49 | VRNA | Verona Pharma plc | 3.18B | 2.00% | 1,155,655 | 5.62M |
| 50 | MLTX | MoonLake Immunotherapeutics | 3.14B | 0.99% | 185,296 | - |
| 51 | AGIO | Agios Pharmaceuticals, Inc. | 3.11B | 0.39% | 367,115 | 32.87M |
| 52 | DYN | Dyne Therapeutics, Inc. | 3.05B | 1.04% | 1,046,561 | - |
| 53 | EWTX | Edgewise Therapeutics, Inc. | 3.03B | 1.40% | 332,369 | - |
| 54 | XENE | Xenon Pharmaceuticals Inc. | 3.00B | 1.26% | 368,159 | - |
| 55 | MRUS | Merus N.V. | 2.94B | -1.29% | 605,265 | 35.93M |
| 56 | VERA | Vera Therapeutics, Inc. | 2.90B | -0.33% | 372,429 | - |
| 57 | FOLD | Amicus Therapeutics, Inc. | 2.87B | 0.74% | 1,901,706 | 493.67M |
| 58 | KYMR | Kymera Therapeutics, Inc. | 2.85B | 2.82% | 368,781 | 87.56M |
| 59 | VCEL | Vericel Corporation | 2.83B | 2.56% | 322,849 | 226.84M |
| 60 | SWTX | SpringWorks Therapeutics, Inc. | 2.78B | -1.29% | 1,158,401 | 135.49M |
| 61 | ACAD | ACADIA Pharmaceuticals Inc. | 2.71B | 0.37% | 1,083,506 | 929.24M |
| 62 | SRRK | Scholar Rock Holding Corporation | 2.61B | - | 656,069 | - |
| 63 | ZLAB | Zai Lab Limited | 2.58B | 0.31% | 1,322,486 | 355.75M |
| 64 | JANX | Janux Therapeutics, Inc. | 2.57B | -0.10% | 378,461 | 13.05M |
| 65 | APGE | Apogee Therapeutics, Inc. | 2.56B | -3.18% | 333,783 | - |
| 66 | BLTE | Belite Bio, Inc | 2.53B | 0.23% | 59,494 | - |
| 67 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.52B | -1.12% | 947,301 | 460.48M |
| 68 | IOVA | Iovance Biotherapeutics, Inc. | 2.48B | -0.61% | 5,978,745 | 90.86M |
| 69 | PTGX | Protagonist Therapeutics, Inc. | 2.42B | 5.17% | 1,047,619 | 323.80M |
| 70 | GERN | Geron Corporation | 2.41B | 5.28% | 9,403,202 | 29.48M |
| 71 | SLNO | Soleno Therapeutics, Inc. | 2.36B | 5.87% | 666,077 | - |
| 72 | LBPH | Longboard Pharmaceuticals, Inc. | 2.33B | -0.12% | 699,774 | - |
| 73 | ARWR | Arrowhead Pharmaceuticals, Inc. | 2.33B | 0.59% | 752,286 | 19.65M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.21B | -1.24% | 526,315 | 3.92M |
| 75 | CNTA | Centessa Pharmaceuticals plc | 2.21B | -0.53% | 619,771 | 6.85M |
| 76 | KROS | Keros Therapeutics, Inc. | 2.19B | 0.97% | 376,662 | 651.00K |
| 77 | CGON | CG Oncology, Inc. | 2.18B | -1.71% | 547,221 | 684.00K |
| 78 | WVE | Wave Life Sciences Ltd. | 2.17B | 0.35% | 655,663 | 53.61M |
| 79 | AKRO | Akero Therapeutics, Inc. | 2.14B | -1.27% | 428,145 | - |
| 80 | LGND | Ligand Pharmaceuticals Incorporated | 2.11B | -0.21% | 133,450 | 152.42M |
| 81 | MIRM | Mirum Pharmaceuticals, Inc. | 2.10B | 3.80% | 353,624 | 307.03M |
| 82 | BEAM | Beam Therapeutics Inc. | 1.95B | -3.16% | 912,776 | 349.64M |
| 83 | MNKD | MannKind Corporation | 1.90B | 0.29% | 1,916,485 | 267.20M |
| 84 | GPCR | Structure Therapeutics Inc. | 1.87B | -0.21% | 484,345 | - |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 1.87B | 0.95% | 296,317 | 681.88M |
| 86 | IRON | Disc Medicine, Inc. | 1.86B | 5.04% | 256,246 | - |
| 87 | NAMS | NewAmsterdam Pharma Company N.V. | 1.85B | -15.50% | 3,010,911 | 33.59M |
| 88 | TARS | Tarsus Pharmaceuticals, Inc. | 1.78B | -0.66% | 313,019 | 129.62M |
| 89 | CLDX | Celldex Therapeutics, Inc. | 1.75B | 5.68% | 1,092,157 | 9.98M |
| 90 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | -3.67% | 14,374,000 | 65.18M |
| 91 | GLPG | Galapagos NV | 1.73B | -3.93% | 515,324 | 290.09M |
| 92 | FTRE | Fortrea Holdings Inc. | 1.72B | 2.52% | 1,193,320 | 2.98B |
| 93 | XNCR | Xencor, Inc. | 1.66B | 0.38% | 508,917 | 85.16M |
| 94 | IMCR | Immunocore Holdings plc | 1.62B | -0.43% | 124,561 | 296.31M |
| 95 | NRIX | Nurix Therapeutics, Inc. | 1.60B | -0.66% | 663,006 | 56.42M |
| 96 | NMRA | Neumora Therapeutics, Inc. | 1.58B | -0.71% | 785,896 | - |
| 97 | VRDN | Viridian Therapeutics, Inc. | 1.57B | -2.22% | 1,008,878 | 302.00K |
| 98 | ARVN | Arvinas, Inc. | 1.56B | 4.85% | 744,028 | 161.10M |
| 99 | TVTX | Travere Therapeutics, Inc. | 1.55B | 2.70% | 878,089 | 203.45M |
| 100 | BCRX | BioCryst Pharmaceuticals, Inc. | 1.51B | 1.25% | 1,566,924 | 412.58M |
| 101 | SYRE | Spyre Therapeutics, Inc. | 1.41B | 2.23% | 1,165,800 | - |
| 102 | BCYC | Bicycle Therapeutics plc | 1.41B | -0.59% | 270,591 | 36.90M |
| 103 | OCUL | Ocular Therapeutix, Inc. | 1.38B | -1.57% | 767,774 | 61.44M |
| 104 | DAWN | Day One Biopharmaceuticals, Inc. | 1.37B | 0.74% | 472,902 | 101.95M |
| 105 | PRAX | Praxis Precision Medicines, Inc. | 1.37B | 1.28% | 334,231 | 1.61M |
| 106 | SNDX | Syndax Pharmaceuticals, Inc. | 1.36B | 1.14% | 1,237,122 | 16.00M |
| 107 | RCUS | Arcus Biosciences, Inc. | 1.34B | 0.76% | 597,884 | 263.00M |
| 108 | NTLA | Intellia Therapeutics, Inc. | 1.34B | -7.15% | 4,414,767 | 43.09M |
| 109 | MDXG | MiMedx Group, Inc. | 1.33B | -1.95% | 946,204 | 342.80M |
| 110 | SPRY | ARS Pharmaceuticals, Inc. | 1.32B | -1.74% | 1,118,377 | 2.57M |
| 111 | NVAX | Novavax, Inc. | 1.29B | 0.75% | 3,165,508 | 885.19M |
| 112 | SAVA | Cassava Sciences, Inc. | 1.25B | -6.96% | 1,822,007 | - |
| 113 | ELVN | Enliven Therapeutics, Inc. | 1.24B | -2.86% | 149,651 | - |
| 114 | KURA | Kura Oncology, Inc. | 1.24B | -0.31% | 615,467 | - |
| 115 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.22B | 4.10% | 1,616,156 | 276.92M |
| 116 | INVA | Innoviva, Inc. | 1.20B | 0.31% | 1,238,451 | 352.75M |
| 117 | ARQT | Arcutis Biotherapeutics, Inc. | 1.19B | 0.89% | 996,797 | 138.71M |
| 118 | RCKT | Rocket Pharmaceuticals, Inc. | 1.19B | -0.91% | 1,256,476 | - |
| 119 | AUPH | Aurinia Pharmaceuticals Inc. | 1.18B | 1.35% | 1,250,145 | 220.36M |
| 120 | ARDX | Ardelyx, Inc. | 1.17B | 2.71% | 4,334,520 | 251.85M |
| 121 | GYRE | Gyre Therapeutics, Inc. | 1.11B | -0.08% | 34,567 | 105.03M |
| 122 | PHVS | Pharvaris N.V. | 1.11B | -0.05% | 51,494 | - |
| 123 | MESO | Mesoblast Limited | 1.10B | -4.53% | 214,657 | 5.90M |
| 124 | APLT | Applied Therapeutics, Inc. | 1.10B | 5.60% | 1,377,067 | -212.00K |
| 125 | COGT | Cogent Biosciences, Inc. | 1.00B | 0.22% | 1,828,826 | - |
| 126 | ZYME | Zymeworks Inc. | 1.00B | -1.49% | 374,217 | 62.20M |
| 127 | BCAX | Bicara Therapeutics Inc. | 1.00B | -4.87% | 361,031 | - |
| 128 | UPB | Upstream Bio, Inc. | 965.27M | -20.80% | 455,532 | 2.21M |
| 129 | SEPN | Septerna, Inc. | 945.06M | -7.02% | 230,373 | 981.00K |
| 130 | ETNB | 89bio, Inc. | 938.31M | -0.13% | 674,160 | - |
| 131 | LENZ | LENZ Therapeutics, Inc. | 932.56M | -2.14% | 92,111 | - |
| 132 | IMTX | Immatics N.V. | 930.98M | -0.13% | 680,099 | 128.82M |
| 133 | VIR | Vir Biotechnology, Inc. | 928.23M | -2.74% | 1,473,612 | 78.62M |
| 134 | AVBP | ArriVent BioPharma, Inc. | 923.64M | -0.04% | 96,391 | - |
| 135 | NUVB | Nuvation Bio Inc. | 868.34M | -0.39% | 3,585,117 | 2.16M |
| 136 | CAPR | Capricor Therapeutics, Inc. | 860.29M | 2.49% | 809,213 | 23.23M |
| 137 | LQDA | Liquidia Corporation | 856.52M | -0.39% | 706,639 | 15.61M |
| 138 | TYRA | Tyra Biosciences, Inc. | 839.08M | -2.10% | 251,372 | - |
| 139 | RAPP | Rapport Therapeutics, Inc. | 811.63M | -0.40% | 124,004 | - |
| 140 | ABCL | AbCellera Biologics Inc. | 788.63M | -1.48% | 1,714,955 | 32.96M |
| 141 | CDMO | Avid Bioservices, Inc. | 781.54M | 0.25% | 1,145,281 | 142.36M |
| 142 | RLAY | Relay Therapeutics, Inc. | 780.00M | -2.92% | 2,886,554 | 10.01M |
| 143 | PRTA | Prothena Corporation plc | 774.85M | 2.49% | 616,562 | 133.35M |
| 144 | PLRX | Pliant Therapeutics, Inc. | 774.67M | -0.47% | 468,630 | - |
| 145 | REPL | Replimune Group, Inc. | 768.33M | 2.56% | 531,852 | - |
| 146 | ERAS | Erasca, Inc. | 746.40M | -5.38% | 720,958 | - |
| 147 | AUTL | Autolus Therapeutics plc | 745.14M | -5.08% | 2,037,795 | 10.09M |
| 148 | CGEM | Cullinan Therapeutics, Inc. | 732.50M | -3.97% | 782,905 | - |
| 149 | CRGX | CARGO Therapeutics, Inc. | 728.16M | -1.80% | 206,616 | - |
| 150 | AVXL | Anavex Life Sciences Corp. | 718.64M | 2.85% | 909,493 | - |
| 151 | BIOA | BioAge Labs, Inc. | 659.62M | -4.02% | 227,301 | - |
| 152 | ADPT | Adaptive Biotechnologies Corporation | 652.30M | -1.34% | 1,806,999 | 177.28M |
| 153 | ABUS | Arbutus Biopharma Corporation | 651.85M | -1.43% | 626,368 | 6.74M |
| 154 | CRMD | CorMedix Inc. | 651.67M | -2.98% | 2,070,900 | 12.26M |
| 155 | TECX | Tectonic Therapeutic, Inc. | 649.56M | 7.76% | 143,223 | - |
| 156 | TRDA | Entrada Therapeutics, Inc. | 634.82M | 0.90% | 64,565 | 215.23M |
| 157 | EXAI | Exscientia plc | 633.50M | 3.20% | 1,454,597 | 22.88M |
| 158 | EYPT | EyePoint Pharmaceuticals, Inc. | 628.28M | -2.77% | 1,373,927 | 45.71M |
| 159 | MLYS | Mineralys Therapeutics, Inc. | 627.09M | -2.02% | 183,072 | - |
| 160 | OCS | Oculis Holding AG | 625.40M | -0.73% | 33,201 | 1.03M |
| 161 | ANAB | AnaptysBio, Inc. | 618.01M | 1.70% | 334,405 | 57.17M |
| 162 | ORIC | ORIC Pharmaceuticals, Inc. | 616.76M | -1.69% | 342,785 | - |
| 163 | TRML | Tourmaline Bio, Inc. | 615.42M | 2.13% | 154,181 | - |
| 164 | DNTH | Dianthus Therapeutics, Inc. | 614.73M | -6.74% | 191,606 | 5.37M |
| 165 | STOK | Stoke Therapeutics, Inc. | 599.06M | -2.58% | 258,772 | 16.74M |
| 166 | PHAT | Phathom Pharmaceuticals, Inc. | 596.93M | -6.83% | 1,335,425 | 26.27M |
| 167 | IMNM | Immunome, Inc. | 582.35M | -0.64% | 547,518 | 10.13M |
| 168 | IGMS | IGM Biosciences, Inc. | 580.67M | 2.36% | 204,686 | 2.92M |
| 169 | ALT | Altimmune, Inc. | 572.55M | 7.76% | 4,683,301 | 52.00K |
| 170 | GHRS | GH Research PLC | 569.71M | 13.94% | 94,500 | - |
| 171 | HUMA | Humacyte, Inc. | 567.43M | -0.23% | 2,053,253 | - |
| 172 | SANA | Sana Biotechnology, Inc. | 564.87M | 7.20% | 1,865,728 | - |
| 173 | CVAC | CureVac N.V. | 558.54M | -0.40% | 855,543 | 70.57M |
| 174 | MREO | Mereo BioPharma Group plc | 554.54M | 2.58% | 727,377 | 1.00M |
| 175 | MNMD | Mind Medicine (MindMed) Inc. | 551.45M | 4.44% | 962,060 | - |
| 176 | ANNX | Annexon, Inc. | 550.02M | -5.49% | 1,542,657 | - |
| 177 | ABVX | ABIVAX Société Anonyme | 547.66M | -0.56% | 30,926 | 9.68M |
| 178 | MBX | MBX Biosciences, Inc. | 542.70M | 1.88% | 166,000 | - |
| 179 | ATXS | Astria Therapeutics, Inc. | 540.64M | -1.74% | 250,423 | - |
| 180 | SVRA | Savara Inc. | 537.17M | 6.46% | 6,068,732 | - |
| 181 | ALMS | Alumis Inc. | 524.49M | -6.86% | 244,986 | - |
| 182 | THRD | Third Harmonic Bio, Inc. | 523.58M | -6.74% | 214,361 | - |
| 183 | ZBIO | Zenas BioPharma, Inc. | 520.30M | -14.14% | 418,910 | - |
| 184 | CRVS | Corvus Pharmaceuticals, Inc. | 515.42M | -1.90% | 518,308 | - |
| 185 | GLUE | Monte Rosa Therapeutics, Inc. | 513.61M | 0.60% | 736,090 | 14.98M |
| 186 | PHAR | Pharming Group N.V. | 500.38M | -0.39% | 8,344 | 285.75M |
| 187 | OPT | Opthea Limited | 499.24M | - | 19,663 | 261.86K |
| 188 | TBPH | Theravance Biopharma, Inc. | 490.27M | 0.50% | 346,407 | 63.19M |
| 189 | PRTC | PureTech Health plc | 489.57M | 1.00% | 2,043 | 468.00K |
| 190 | URGN | UroGen Pharma Ltd. | 483.18M | 2.60% | 330,421 | 89.36M |
| 191 | PROK | ProKidney Corp. | 481.24M | -8.33% | 327,987 | - |
| 192 | ZVRA | Zevra Therapeutics, Inc. | 478.78M | - | 570,576 | 24.49M |
| 193 | RGNX | REGENXBIO Inc. | 477.12M | 0.73% | 798,141 | 84.33M |
| 194 | TERN | Terns Pharmaceuticals, Inc. | 475.66M | -5.25% | 1,216,371 | - |
| 195 | CELC | Celcuity Inc. | 474.52M | 2.49% | 261,713 | - |
| 196 | OLMA | Olema Pharmaceuticals, Inc. | 474.09M | -5.05% | 343,472 | - |
| 197 | YMAB | Y-mAbs Therapeutics, Inc. | 472.08M | -2.95% | 219,968 | 84.55M |
| 198 | OABI | OmniAb, Inc. | 471.95M | 1.56% | 622,080 | 20.41M |
| 199 | XERS | Xeris Biopharma Holdings, Inc. | 456.19M | 1.66% | 1,049,869 | 187.36M |
| 200 | MGTX | MeiraGTx Holdings plc | 454.85M | -2.68% | 240,862 | 13.93M |
| 201 | SLRN | Acelyrin, Inc. | 444.44M | -6.14% | 338,136 | - |
| 202 | KRRO | Korro Bio, Inc. | 440.31M | 0.79% | 124,925 | - |
| 203 | TNGX | Tango Therapeutics, Inc. | 438.26M | 5.97% | 2,482,775 | 43.38M |
| 204 | ARCT | Arcturus Therapeutics Holdings Inc. | 438.00M | -10.47% | 446,697 | 160.40M |
| 205 | AURA | Aura Biosciences, Inc. | 437.08M | -1.91% | 247,563 | - |
| 206 | FHTX | Foghorn Therapeutics Inc. | 436.96M | 0.77% | 76,400 | 25.52M |
| 207 | RNAC | Cartesian Therapeutics, Inc. | 430.53M | -3.48% | 113,792 | 47.94M |
| 208 | ALLO | Allogene Therapeutics, Inc. | 429.83M | -3.30% | 2,418,927 | 43.00K |
| 209 | RIGL | Rigel Pharmaceuticals, Inc. | 428.22M | 1.67% | 168,437 | 157.37M |
| 210 | TSHA | Taysha Gene Therapies, Inc. | 411.94M | -5.19% | 5,013,096 | 9.92M |
| 211 | SGMO | Sangamo Therapeutics, Inc. | 406.86M | -0.51% | 6,587,392 | 52.29M |
| 212 | RVNC | Revance Therapeutics, Inc. | 398.63M | 1.06% | 1,457,571 | 256.95M |
| 213 | FDMT | 4D Molecular Therapeutics, Inc. | 388.78M | -3.00% | 639,444 | 17.00K |
| 214 | LRMR | Larimar Therapeutics, Inc. | 387.94M | -4.70% | 666,422 | - |
| 215 | KALV | KalVista Pharmaceuticals, Inc. | 387.21M | -0.99% | 406,868 | - |
| 216 | VERV | Verve Therapeutics, Inc. | 385.22M | -5.99% | 1,412,288 | 24.40M |
| 217 | ENGN | enGene Holdings Inc. | 382.33M | -0.27% | 61,923 | - |
| 218 | PRME | Prime Medicine, Inc. | 381.51M | -5.68% | 1,144,404 | 800.00K |
| 219 | PRQR | ProQR Therapeutics N.V. | 378.76M | 1.94% | 234,265 | 20.51M |
| 220 | VALN | Valneva SE | 361.62M | 1.74% | 39,047 | 176.82M |
| 221 | AMLX | Amylyx Pharmaceuticals, Inc. | 356.07M | 0.19% | 932,817 | 196.49M |
| 222 | ALEC | Alector, Inc. | 355.99M | -5.58% | 503,156 | 61.51M |
| 223 | DNA | Ginkgo Bioworks Holdings, Inc. | 354.32M | -1.40% | 998,541 | 217.95M |
| 224 | XOMA | XOMA Royalty Corporation | 353.72M | -0.27% | 17,846 | 21.61M |
| 225 | CDXS | Codexis, Inc. | 352.37M | 1.88% | 800,105 | 64.45M |
| 226 | CTNM | Contineum Therapeutics, Inc. | 351.87M | 2.63% | 80,011 | - |
| 227 | OMER | Omeros Corporation | 349.44M | - | 364,013 | - |
| 228 | QTTB | Q32 Bio Inc. | 332.29M | -6.22% | 142,583 | -14.66M |
| 229 | SLN | Silence Therapeutics plc | 324.31M | -0.57% | 2,330,066 | 21.77M |
| 230 | ACIU | AC Immune SA | 320.57M | -0.92% | 57,974 | 48.51M |
| 231 | JSPR | Jasper Therapeutics, Inc. | 314.73M | 1.40% | 210,947 | - |
| 232 | DSGN | Design Therapeutics, Inc. | 310.28M | - | 51,859 | - |
| 233 | ABSI | Absci Corporation | 307.81M | -1.47% | 1,056,551 | 4.21M |
| 234 | KOD | Kodiak Sciences Inc. | 303.98M | 2.66% | 337,616 | - |
| 235 | SAGE | Sage Therapeutics, Inc. | 300.36M | - | 1,567,593 | 106.40M |
| 236 | NAUT | Nautilus Biotechnology, Inc. | 293.82M | 4.46% | 65,186 | - |
| 237 | VYGR | Voyager Therapeutics, Inc. | 292.79M | 1.71% | 437,434 | 163.78M |
| 238 | LXRX | Lexicon Pharmaceuticals, Inc. | 291.87M | -8.34% | 3,064,202 | 5.23M |
| 239 | IMMP | Immutep Limited | 287.86M | -2.97% | 72,991 | 2.56M |
| 240 | LYEL | Lyell Immunopharma, Inc. | 287.60M | -7.21% | 4,652,063 | 63.00K |
| 241 | ITOS | iTeos Therapeutics, Inc. | 286.79M | -0.63% | 493,785 | 35.00M |
| 242 | CCCC | C4 Therapeutics, Inc. | 285.89M | -2.41% | 1,298,083 | 33.67M |
| 243 | VNDA | Vanda Pharmaceuticals Inc. | 285.71M | -0.41% | 396,102 | 190.86M |
| 244 | ALDX | Aldeyra Therapeutics, Inc. | 283.46M | -3.64% | 586,843 | - |
| 245 | RZLT | Rezolute, Inc. | 280.20M | 1.21% | 275,837 | - |
| 246 | QURE | uniQure N.V. | 277.84M | -2.06% | 957,449 | 28.59M |
| 247 | MRSN | Mersana Therapeutics, Inc. | 274.24M | - | 664,109 | 34.84M |
| 248 | OCGN | Ocugen, Inc. | 267.58M | 5.14% | 4,286,751 | 4.70M |
| 249 | AVIR | Atea Pharmaceuticals, Inc. | 266.90M | 0.64% | 167,552 | - |
| 250 | ATAI | Atai Life Sciences N.V. | 266.80M | -8.09% | 2,332,240 | 331.00K |
| 251 | ARTV | Artiva Biotherapeutics, Inc. | 266.21M | -3.01% | 24,624 | 2.60M |
| 252 | PSTX | Poseida Therapeutics, Inc. | 265.10M | -1.81% | 434,467 | 150.86M |
| 253 | FATE | Fate Therapeutics, Inc. | 252.85M | 1.83% | 2,372,373 | 13.45M |
| 254 | ABEO | Abeona Therapeutics Inc. | 250.66M | -2.38% | 214,575 | - |
| 255 | TVGN | Tevogen Bio Holdings Inc. | 248.57M | 4.41% | 20,644,159 | - |
| 256 | BNTC | Benitec Biopharma Inc. | 247.49M | 7.89% | 62,171 | - |
| 257 | PGEN | Precigen, Inc. | 245.04M | 5.17% | 654,252 | 3.96M |
| 258 | IVA | Inventiva S.A. | 236.24M | -0.72% | 6,663 | 20.65M |
| 259 | DRUG | Bright Minds Biosciences Inc. | 233.14M | -11.87% | 86,229 | - |
| 260 | ELDN | Eledon Pharmaceuticals, Inc. | 230.00M | -0.77% | 423,637 | - |
| 261 | BMEA | Biomea Fusion, Inc. | 227.58M | -2.18% | 542,822 | - |
| 262 | PYXS | Pyxis Oncology, Inc. | 227.16M | -8.17% | 937,287 | 16.15M |
| 263 | CYBN | Cybin Inc. | 227.14M | 1.45% | 322,759 | - |
| 264 | ATYR | aTyr Pharma, Inc. | 226.63M | -1.64% | 520,475 | 235.00K |
| 265 | ZNTL | Zentalis Pharmaceuticals, Inc. | 223.06M | 4.68% | 1,192,225 | 40.56M |
| 266 | STRO | Sutro Biopharma, Inc. | 220.16M | -1.11% | 877,681 | 160.96M |
| 267 | TCRX | TScan Therapeutics, Inc. | 219.89M | -2.14% | 158,870 | 9.36M |
| 268 | OKUR | OnKure Therapeutics, Inc. | 213.43M | -2.38% | 19,642 | - |
| 269 | TRVI | Trevi Therapeutics, Inc. | 212.92M | -7.67% | 387,407 | - |
| 270 | GNFT | Genfit S.A. | 211.03M | -3.79% | 1,973 | 86.23M |
| 271 | CLYM | Climb Bio, Inc. | 207.05M | -5.23% | 125,959 | - |
| 272 | MGNX | MacroGenics, Inc. | 205.86M | -5.75% | 644,270 | 141.33M |
| 273 | INBX | Inhibrx Biosciences, Inc. | 203.24M | -1.75% | 86,565 | 1.57M |
| 274 | ACRV | Acrivon Therapeutics, Inc. | 202.39M | 1.88% | 30,283 | - |
| 275 | LXEO | Lexeo Therapeutics, Inc. | 202.36M | 1.66% | 231,562 | - |
| 276 | OBIO | Orchestra BioMed Holdings, Inc. | 200.71M | 2.13% | 33,140 | 2.65M |
| 277 | MOLN | Molecular Partners AG | 199.84M | -3.88% | 29,907 | 7.11M |
| 278 | NGNE | Neurogene Inc. | 199.19M | -11.03% | 796,362 | 925.00K |
| 279 | EDIT | Editas Medicine, Inc. | 198.94M | -2.82% | 2,803,065 | 61.76M |
| 280 | SLDB | Solid Biosciences Inc. | 198.17M | -2.94% | 374,901 | - |
| 281 | XBIT | XBiotech Inc. | 197.84M | -2.70% | 48,635 | - |
| 282 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 195.85M | -2.90% | 257,214 | - |
| 283 | ENTA | Enanta Pharmaceuticals, Inc. | 192.39M | -3.61% | 155,278 | 71.96M |
| 284 | ADCT | ADC Therapeutics SA | 191.45M | -3.88% | 420,581 | 70.72M |
| 285 | ZURA | Zura Bio Limited | 189.35M | -7.94% | 473,307 | - |
| 286 | CMPX | Compass Therapeutics, Inc. | 188.50M | -3.52% | 298,412 | 850.00K |
| 287 | NKTR | Nektar Therapeutics | 184.46M | -2.91% | 1,476,216 | 93.14M |
| 288 | CLLS | Cellectis S.A. | 182.72M | -2.55% | 26,155 | 36.04M |
| 289 | MDWD | MediWound Ltd. | 181.06M | 6.20% | 76,994 | 20.14M |
| 290 | INZY | Inozyme Pharma, Inc. | 179.23M | -0.71% | 389,376 | - |
| 291 | NBTX | Nanobiotix S.A. | 178.35M | 7.63% | 14,656 | 45.22M |
| 292 | KYTX | Kyverna Therapeutics, Inc. | 177.87M | 0.98% | 264,078 | - |
| 293 | CRBU | Caribou Biosciences, Inc. | 177.48M | -1.51% | 2,229,854 | 11.48M |
| 294 | GALT | Galectin Therapeutics Inc. | 176.67M | 2.18% | 130,993 | - |
| 295 | NKTX | Nkarta, Inc. | 176.42M | 0.81% | 995,929 | - |
| 296 | TNYA | Tenaya Therapeutics, Inc. | 175.87M | -2.20% | 4,667,574 | - |
| 297 | DMAC | DiaMedica Therapeutics Inc. | 171.92M | -0.50% | 40,777 | - |
| 298 | HRTX | Heron Therapeutics, Inc. | 170.35M | -5.88% | 1,708,776 | 137.74M |
| 299 | ADAP | Adaptimmune Therapeutics plc | 169.99M | -1.50% | 4,158,652 | 175.04M |
| 300 | GLSI | Greenwich LifeSciences, Inc. | 168.91M | 0.63% | 30,266 | - |
| 301 | VSTM | Verastem, Inc. | 168.68M | -4.29% | 452,174 | 10.00M |
| 302 | SCPH | scPharmaceuticals Inc. | 168.13M | -4.55% | 306,943 | 30.28M |
| 303 | ACTU | Actuate Therapeutics, Inc. | 167.58M | -3.16% | 39,756 | - |
| 304 | FULC | Fulcrum Therapeutics, Inc. | 161.28M | -0.66% | 731,597 | 80.87M |
| 305 | DRTS | Alpha Tau Medical Ltd. | 160.48M | -0.22% | 13,188 | - |
| 306 | TSVT | 2seventy bio, Inc. | 160.44M | -3.42% | 314,655 | 45.62M |
| 307 | GOSS | Gossamer Bio, Inc. | 157.57M | -2.56% | 1,002,213 | 105.32M |
| 308 | TIL | Instil Bio, Inc. | 152.44M | -10.84% | 90,008 | - |
| 309 | CKPT | Checkpoint Therapeutics, Inc. | 152.16M | - | 559,785 | 47.00K |
| 310 | ATOS | Atossa Therapeutics, Inc. | 150.96M | -6.25% | 1,322,565 | - |
| 311 | ACHV | Achieve Life Sciences, Inc. | 148.05M | -0.81% | 72,709 | - |
| 312 | SGMT | Sagimet Biosciences Inc. | 144.25M | 2.49% | 258,873 | - |
| 313 | PEPG | PepGen Inc. | 143.42M | -1.57% | 50,517 | - |
| 314 | ABOS | Acumen Pharmaceuticals, Inc. | 142.39M | -0.84% | 180,507 | - |
| 315 | PBYI | Puma Biotechnology, Inc. | 139.41M | 3.65% | 266,707 | 243.57M |
| 316 | MCRB | Seres Therapeutics, Inc. | 138.53M | 18.23% | 12,175,788 | 126.33M |
| 317 | VXRT | Vaxart, Inc. | 138.24M | -1.97% | 819,842 | 16.76M |
| 318 | BDTX | Black Diamond Therapeutics, Inc. | 137.50M | -4.71% | 462,097 | - |
| 319 | SEER | Seer, Inc. | 135.03M | 0.44% | 261,374 | 14.61M |
| 320 | IPHA | Innate Pharma S.A. | 134.83M | 13.12% | 7,547 | 36.20M |
| 321 | IKT | Inhibikase Therapeutics, Inc. | 133.04M | -1.00% | 119,419 | 1.00 |
| 322 | SKYE | Skye Bioscience, Inc. | 129.85M | -1.38% | 106,139 | - |
| 323 | CRDF | Cardiff Oncology, Inc. | 129.37M | -3.44% | 486,778 | 688.00K |
| 324 | CADL | Candel Therapeutics, Inc. | 129.25M | -0.25% | 336,904 | - |
| 325 | ADVM | Adverum Biotechnologies, Inc. | 128.35M | -1.28% | 214,318 | 1.00M |
| 326 | CGEN | Compugen Ltd. | 128.04M | -0.69% | 227,984 | 59.85M |
| 327 | EPRX | Eupraxia Pharmaceuticals Inc. | 127.94M | 11.80% | 235,580 | - |
| 328 | FENC | Fennec Pharmaceuticals Inc. | 127.29M | 8.54% | 186,809 | 49.35M |
| 329 | CHRS | Coherus BioSciences, Inc. | 126.73M | 33.90% | 8,704,367 | 304.34M |
| 330 | OTLK | Outlook Therapeutics, Inc. | 124.90M | 0.96% | 137,605 | - |
| 331 | TELO | Telomir Pharmaceuticals, Inc. | 124.36M | -5.41% | 96,468 | - |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 124.29M | 3.68% | 817,071 | 45.67M |
| 333 | MIST | Milestone Pharmaceuticals Inc. | 123.20M | 6.90% | 608,906 | - |
| 334 | AVTX | Avalo Therapeutics, Inc. | 122.57M | -1.36% | 49,260 | 820.00K |
| 335 | CNTX | Context Therapeutics Inc. | 122.25M | -1.21% | 129,005 | - |
| 336 | VTYX | Ventyx Biosciences, Inc. | 121.62M | -3.37% | 1,231,553 | - |
| 337 | VIGL | Vigil Neuroscience, Inc. | 120.92M | 0.33% | 52,993 | - |
| 338 | LCTX | Lineage Cell Therapeutics, Inc. | 120.86M | -28.89% | 9,878,295 | 8.72M |
| 339 | RPTX | Repare Therapeutics Inc. | 120.73M | -1.39% | 96,069 | 66.52M |
| 340 | IFRX | InflaRx N.V. | 120.12M | 6.25% | 370,130 | 187.93K |
| 341 | CBUS | Cibus, Inc. | 117.39M | -8.53% | 142,214 | 4.15M |
| 342 | RANI | Rani Therapeutics Holdings, Inc. | 115.63M | -0.24% | 420,915 | - |
| 343 | ANRO | Alto Neuroscience, Inc. | 115.16M | -4.69% | 320,793 | - |
| 344 | CABA | Cabaletta Bio, Inc. | 110.46M | -11.02% | 2,472,861 | - |
| 345 | IPSC | Century Therapeutics, Inc. | 107.14M | -1.56% | 414,662 | 2.68M |
| 346 | CDTX | Cidara Therapeutics, Inc. | 106.55M | -3.26% | 45,617 | 44.65M |
| 347 | CAMP | Camp4 Therapeutics Corporation | 103.96M | -19.36% | 65,441 | 350.00K |
| 348 | INO | Inovio Pharmaceuticals, Inc. | 103.62M | -1.49% | 422,594 | 203.41K |
| 349 | TLSA | Tiziana Life Sciences Ltd | 102.46M | 2.03% | 89,615 | - |
| 350 | INMB | INmune Bio, Inc. | 101.11M | -3.18% | 184,695 | 42.00K |
| 351 | MNPR | Monopar Therapeutics Inc. | 100.28M | -0.05% | 120,942 | - |
| 352 | LPTX | Leap Therapeutics, Inc. | 99.10M | -4.07% | 208,833 | - |
| 353 | GUTS | Fractyl Health, Inc. | 99.08M | -5.94% | 292,609 | 97.00K |
| 354 | ANIX | Anixa Biosciences, Inc. | 97.99M | -2.40% | 30,733 | - |
| 355 | KPTI | Karyopharm Therapeutics Inc. | 97.12M | 0.26% | 367,088 | 148.44M |
| 356 | IMUX | Immunic, Inc. | 96.38M | 1.90% | 481,652 | - |
| 357 | MNOV | MediciNova, Inc. | 95.64M | 2.63% | 59,646 | - |
| 358 | ASMB | Assembly Biosciences, Inc. | 95.47M | -2.09% | 19,195 | 28.33M |
| 359 | ANL | Adlai Nortye Ltd. | 95.20M | -13.71% | 32,182 | 5.00M |
| 360 | NVCT | Nuvectis Pharma, Inc. | 94.57M | -1.36% | 153,802 | - |
| 361 | ADAG | Adagene Inc. | 92.53M | -12.18% | 21,931 | 815.75K |
| 362 | IVVD | Invivyd, Inc. | 91.88M | 0.09% | 1,029,172 | 11.56M |
| 363 | COYA | Coya Therapeutics, Inc. | 91.78M | -0.66% | 37,329 | 9.55M |
| 364 | RGLS | Regulus Therapeutics Inc. | 91.70M | -1.41% | 147,780 | - |
| 365 | VERU | Veru Inc. | 91.53M | -0.30% | 597,344 | 14.09M |
| 366 | ORMP | Oramed Pharmaceuticals Inc. | 91.11M | -1.74% | 60,576 | - |
| 367 | GBIO | Generation Bio Co. | 90.17M | -2.88% | 182,347 | 18.58M |
| 368 | HLVX | HilleVax, Inc. | 86.34M | -1.65% | 96,231 | - |
| 369 | RLMD | Relmada Therapeutics, Inc. | 86.00M | -4.36% | 174,300 | - |
| 370 | GNTA | Genenta Science S.p.A. | 85.96M | -2.49% | 8,524 | - |
| 371 | ANVS | Annovis Bio, Inc. | 85.37M | -2.10% | 158,013 | - |
| 372 | GNLX | Genelux Corporation | 84.91M | 0.40% | 189,069 | 8.00K |
| 373 | ALLK | Allakos Inc. | 83.91M | -7.01% | 551,092 | - |
| 374 | IKNA | Ikena Oncology, Inc. | 82.04M | 1.19% | 15,786 | 659.00K |
| 375 | PMVP | PMV Pharmaceuticals, Inc. | 81.24M | -1.26% | 108,185 | - |
| 376 | QNCX | Quince Therapeutics, Inc. | 80.96M | 3.95% | 138,602 | - |
| 377 | RENB | Renovaro Inc. | 79.96M | 6.47% | 448,217 | - |
| 378 | IMAB | I-Mab | 79.81M | 2.83% | 159,878 | 3.31M |
| 379 | SLS | SELLAS Life Sciences Group, Inc. | 79.77M | -3.88% | 987,232 | - |
| 380 | ACET | Adicet Bio, Inc. | 79.69M | -6.11% | 961,781 | - |
| 381 | CLSD | Clearside Biomedical, Inc. | 79.64M | 1.94% | 169,380 | 7.70M |
| 382 | CRVO | CervoMed Inc. | 79.57M | -4.37% | 62,523 | 10.07M |
| 383 | CASI | CASI Pharmaceuticals, Inc. | 79.16M | -1.31% | 62,740 | 22.06M |
| 384 | CMRX | Chimerix, Inc. | 79.14M | - | 145,922 | 159.00K |
| 385 | FBLG | FibroBiologics, Inc. | 77.64M | -5.88% | 181,886 | - |
| 386 | ONCY | Oncolytics Biotech Inc. | 77.05M | -5.80% | 274,064 | - |
| 387 | AVTE | Aerovate Therapeutics, Inc. | 76.81M | -0.37% | 386,978 | - |
| 388 | EPIX | ESSA Pharma Inc. | 76.76M | -0.57% | 196,304 | - |
| 389 | ARMP | Armata Pharmaceuticals, Inc. | 75.62M | 5.56% | 18,394 | 5.47M |
| 390 | PDSB | PDS Biotechnology Corporation | 74.56M | -3.34% | 430,241 | - |
| 391 | OVID | Ovid Therapeutics Inc. | 73.85M | 0.97% | 212,321 | 631.70K |
| 392 | HOWL | Werewolf Therapeutics, Inc. | 73.08M | -1.80% | 477,001 | 3.39M |
| 393 | BCAB | BioAtla, Inc. | 71.55M | -1.33% | 629,427 | 11.00M |
| 394 | VANI | Vivani Medical, Inc. | 71.28M | - | 128,297 | - |
| 395 | VTGN | Vistagen Therapeutics, Inc. | 70.61M | -2.25% | 234,117 | 876.00K |
| 396 | BYSI | BeyondSpring Inc. | 68.91M | -0.58% | 15,749 | 1.88M |
| 397 | CTMX | CytomX Therapeutics, Inc. | 68.09M | -2.53% | 427,650 | 126.62M |
| 398 | ALGS | Aligos Therapeutics, Inc. | 67.55M | -1.62% | 471,621 | 6.00M |
| 399 | CUE | Cue Biopharma, Inc. | 65.63M | 0.93% | 408,699 | 9.53M |
| 400 | ALVR | AlloVir, Inc. | 65.16M | 1.93% | 644,910 | - |
| 401 | SPRO | Spero Therapeutics, Inc. | 64.86M | 3.45% | 325,135 | 106.46M |
| 402 | CELU | Celularity Inc. | 64.70M | 0.68% | 120,754 | 42.69M |
| 403 | ALXO | ALX Oncology Holdings Inc. | 63.82M | -1.63% | 578,155 | - |
| 404 | AGEN | Agenus Inc. | 62.64M | 3.89% | 502,406 | 160.43M |
| 405 | MGX | Metagenomi, Inc. | 61.75M | -2.37% | 684,574 | 55.08M |
| 406 | ATRA | Atara Biotherapeutics, Inc. | 60.60M | -2.82% | 108,219 | 100.44M |
| 407 | IMRX | Immuneering Corporation | 60.49M | - | 175,167 | - |
| 408 | BOLD | Boundless Bio, Inc. | 60.43M | 0.74% | 48,790 | - |
| 409 | ALRN | Aileron Therapeutics, Inc. | 59.80M | -2.13% | 114,645 | - |
| 410 | BLUE | bluebird bio, Inc. | 58.92M | -0.69% | 3,403,165 | 53.12M |
| 411 | CSBR | Champions Oncology, Inc. | 58.73M | -5.05% | 22,550 | 51.66M |
| 412 | XFOR | X4 Pharmaceuticals, Inc. | 58.05M | -7.50% | 3,218,566 | 1.12M |
| 413 | CNTB | Connect Biopharma Holdings Limited | 58.02M | 9.38% | 12,728 | 24.12M |
| 414 | MURA | Mural Oncology plc | 57.56M | - | 42,085 | - |
| 415 | ENTX | Entera Bio Ltd. | 57.09M | -4.91% | 48,204 | 99.00K |
| 416 | CLRB | Cellectar Biosciences, Inc. | 55.92M | -3.11% | 739,316 | - |
| 417 | THTX | Theratechnologies Inc. | 55.81M | 1.67% | 35,817 | 84.32M |
| 418 | NTRB | Nutriband Inc. | 55.26M | 1.43% | 12,849 | 1.80M |
| 419 | AADI | Aadi Bioscience, Inc. | 54.72M | 0.45% | 61,649 | 25.07M |
| 420 | KZR | Kezar Life Sciences, Inc. | 54.65M | 1.49% | 106,646 | - |
| 421 | VOR | Vor Biopharma Inc. | 54.58M | 3.87% | 208,229 | - |
| 422 | IOBT | IO Biotech, Inc. | 54.06M | -5.68% | 297,659 | - |
| 423 | ELTX | Elicio Therapeutics, Inc. | 53.91M | -0.99% | 34,396 | - |
| 424 | MAIA | MAIA Biotechnology, Inc. | 53.45M | 1.83% | 56,411 | - |
| 425 | DBVT | DBV Technologies S.A. | 53.27M | 1.60% | 68,277 | 12.52M |
| 426 | STTK | Shattuck Labs, Inc. | 52.99M | -2.63% | 164,958 | 6.44M |
| 427 | PRLD | Prelude Therapeutics Incorporated | 52.93M | 0.17% | 205,998 | 3.00M |
| 428 | UNCY | Unicycive Therapeutics, Inc. | 52.87M | 5.03% | 1,676,765 | - |
| 429 | DTIL | Precision BioSciences, Inc. | 51.94M | 0.28% | 68,894 | 75.10M |
| 430 | KRON | Kronos Bio, Inc. | 51.85M | 1.18% | 249,194 | 9.86M |
| 431 | IMMX | Immix Biopharma, Inc. | 50.06M | 7.06% | 439,233 | - |
| 432 | LSB | LakeShore Biopharma Co., Ltd | 49.99M | 5.22% | 6,341 | 79.42M |
| 433 | CLGN | CollPlant Biotechnologies Ltd. | 48.45M | -0.47% | 9,142 | 689.00K |
| 434 | TARA | Protara Therapeutics, Inc. | 47.65M | -0.43% | 26,859 | - |
| 435 | SER | Serina Therapeutics, Inc. | 46.77M | 5.20% | 25,435 | 3.16M |
| 436 | VTVT | vTv Therapeutics Inc. | 46.54M | -5.90% | 16,217 | 1.00M |
| 437 | CALC | CalciMedica, Inc. | 46.47M | 2.99% | 11,707 | - |
| 438 | CLDI | Calidi Biotherapeutics, Inc. | 44.23M | -4.58% | 1,252,155 | - |
| 439 | DYAI | Dyadic International, Inc. | 44.09M | 22.13% | 466,663 | 3.36M |
| 440 | ACHL | Achilles Therapeutics plc | 43.96M | 1.90% | 83,951 | - |
| 441 | OMGA | Omega Therapeutics, Inc. | 43.58M | 3.97% | 220,031 | 8.10M |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 43.36M | -2.11% | 285,203 | 81.00K |
| 443 | FBIO | Fortress Biotech, Inc. | 43.27M | -1.26% | 376,835 | 81.50M |
| 444 | AFMD | Affimed N.V. | 42.65M | -9.33% | 346,461 | 6.29M |
| 445 | GANX | Gain Therapeutics, Inc. | 42.39M | -3.49% | 141,663 | - |
| 446 | VYNE | VYNE Therapeutics Inc. | 41.60M | 3.30% | 57,666 | 493.00K |
| 447 | XLO | Xilio Therapeutics, Inc. | 41.37M | -7.73% | 298,649 | 4.62M |
| 448 | RLYB | Rallybio Corporation | 41.24M | 3.51% | 49,911 | 598.00K |
| 449 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 40.63M | -3.57% | 252,301 | - |
| 450 | INTS | Intensity Therapeutics, Inc. | 40.63M | -1.67% | 9,272 | - |
| 451 | VRCA | Verrica Pharmaceuticals Inc. | 40.47M | -0.29% | 226,422 | 9.21M |
| 452 | BLRX | BioLineRx Ltd. | 40.40M | 1.36% | 362,805 | 17.05M |
| 453 | LVTX | LAVA Therapeutics N.V. | 39.97M | -2.25% | 25,063 | 7.40M |
| 454 | ANEB | Anebulo Pharmaceuticals, Inc. | 39.42M | - | 3,536 | - |
| 455 | ANTX | AN2 Therapeutics, Inc. | 38.80M | 22.64% | 5,495,081 | - |
| 456 | CVM | CEL-SCI Corporation | 38.62M | -3.38% | 533,340 | - |
| 457 | LEXX | Lexaria Bioscience Corp. | 38.40M | 1.38% | 101,631 | 411.02K |
| 458 | RAPT | RAPT Therapeutics, Inc. | 37.41M | - | 843,332 | - |
| 459 | CERO | CERo Therapeutics Holdings, Inc. | 37.40M | -3.60% | 13,810,138 | - |
| 460 | LUMO | Lumos Pharma, Inc. | 37.36M | -0.23% | 83,157 | 2.21M |
| 461 | ITRM | Iterum Therapeutics plc | 37.01M | 7.24% | 1,036,451 | - |
| 462 | NXTC | NextCure, Inc. | 36.37M | -0.76% | 5,003 | - |
| 463 | OKYO | OKYO Pharma Limited | 36.20M | 3.88% | 53,426 | - |
| 464 | BRNS | Barinthus Biotherapeutics plc | 36.17M | 1.24% | 50,228 | 14.97M |
| 465 | OSTX | OS Therapies Incorporated | 36.03M | -2.54% | 36,862 | - |
| 466 | CARM | Carisma Therapeutics, Inc. | 36.01M | -0.54% | 75,662 | 20.27M |
| 467 | HCWB | HCW Biologics Inc. | 35.83M | -13.89% | 7,173,231 | 3.50M |
| 468 | FGEN | FibroGen, Inc. | 35.27M | - | 1,292,952 | 180.02M |
| 469 | ELEV | Elevation Oncology, Inc. | 34.35M | 0.19% | 289,267 | - |
| 470 | TNXP | Tonix Pharmaceuticals Holding Corp. | 33.93M | 16.78% | 655,114,298 | 11.29M |
| 471 | ESLA | Estrella Immunopharma, Inc. | 33.31M | 8.17% | 29,457 | - |
| 472 | GRCE | Grace Therapeutics, Inc. | 33.26M | 2.50% | 61,082 | - |
| 473 | MLEC | Moolec Science SA | 32.87M | -1.72% | 18,448 | 5.63M |
| 474 | CTXR | Citius Pharmaceuticals, Inc. | 32.82M | -11.42% | 4,178,591 | - |
| 475 | HOOK | HOOKIPA Pharma Inc. | 32.79M | -2.51% | 56,464 | 50.00M |
| 476 | PASG | Passage Bio, Inc. | 31.73M | 6.58% | 335,199 | - |
| 477 | LTRN | Lantern Pharma Inc. | 31.65M | -4.55% | 71,133 | - |
| 478 | ERNA | Eterna Therapeutics Inc. | 31.58M | -9.82% | 334,098 | 598.00K |
| 479 | CRIS | Curis, Inc. | 31.00M | -2.37% | 59,390 | 10.26M |
| 480 | IRD | Opus Genetics, Inc. | 30.81M | 10.94% | 189,059 | 8.38M |
| 481 | BIVI | BioVie Inc. | 30.50M | -4.27% | 1,504,240 | - |
| 482 | IBO | Impact BioMedical Inc. | 30.49M | 5.58% | 53,736 | - |
| 483 | KALA | KALA BIO, Inc. | 29.63M | 0.78% | 39,275 | - |
| 484 | NRXS | NeurAxis, Inc. | 28.97M | -1.85% | 19,867 | 2.46M |
| 485 | RNXT | RenovoRx, Inc. | 28.54M | 7.21% | 249,254 | - |
| 486 | SRZN | Surrozen, Inc. | 28.53M | -11.09% | 45,311 | 10.00M |
| 487 | MRKR | Marker Therapeutics, Inc. | 28.37M | -0.31% | 17,893 | 5.40M |
| 488 | SABS | SAB Biotherapeutics, Inc. | 28.24M | -5.56% | 69,444 | 1.51M |
| 489 | ICCC | ImmuCell Corporation | 28.20M | - | 7,933 | 23.84M |
| 490 | PLUR | Pluri Inc. | 28.13M | 1.20% | 6,267 | 598.00K |
| 491 | INKT | MiNK Therapeutics, Inc. | 27.87M | 2.61% | 21,658 | - |
| 492 | DARE | Daré Bioscience, Inc. | 27.18M | - | 20,611 | 1.88M |
| 493 | LGVN | Longeveron Inc. | 26.57M | - | 160,675 | 1.85M |
| 494 | IGC | IGC Pharma, Inc. | 25.56M | -2.94% | 186,170 | 1.18M |
| 495 | GDTC | CytoMed Therapeutics Limited | 25.51M | 8.34% | 17,541 | 330.25K |
| 496 | EQ | Equillium, Inc. | 25.44M | 2.59% | 35,678 | 45.91M |
| 497 | LPCN | Lipocine Inc. | 25.19M | -1.05% | 4,682 | 7.92M |
| 498 | ATHA | Athira Pharma, Inc. | 24.69M | -1.00% | 253,362 | - |
| 499 | GOVX | GeoVax Labs, Inc. | 24.63M | -10.31% | 1,238,346 | 3.09M |
| 500 | LSTA | Lisata Therapeutics, Inc. | 24.38M | 6.55% | 53,072 | - |
| 501 | BTAI | BioXcel Therapeutics, Inc. | 23.96M | -2.44% | 372,885 | 2.28M |
| 502 | OCEA | Ocean Biomedical, Inc. | 23.91M | -3.99% | 24,959 | - |
| 503 | TPST | Tempest Therapeutics, Inc. | 23.87M | 3.85% | 961,073 | - |
| 504 | PYPD | PolyPid Ltd. | 23.74M | -3.59% | 52,182 | - |
| 505 | CMMB | Chemomab Therapeutics Ltd. | 23.55M | 1.23% | 101,775 | - |
| 506 | INAB | IN8bio, Inc. | 23.30M | 1.42% | 117,800 | - |
| 507 | ACXP | Acurx Pharmaceuticals, Inc. | 22.58M | -16.77% | 1,070,086 | - |
| 508 | AEON | AEON Biopharma, Inc. | 22.27M | -2.83% | 99,219 | - |
| 509 | BOLT | Bolt Biotherapeutics, Inc. | 21.81M | 1.59% | 59,991 | 9.78M |
| 510 | BCTX | BriaCell Therapeutics Corp. | 21.75M | 5.37% | 621,585 | - |
| 511 | CVKD | Cadrenal Therapeutics, Inc. | 21.70M | -4.16% | 53,596 | - |
| 512 | XTLB | XTL Biopharmaceuticals Ltd. | 21.45M | -1.67% | 2,165 | - |
| 513 | GLYC | GlycoMimetics, Inc. | 21.28M | -12.95% | 3,459,408 | 10.00K |
| 514 | PIRS | Pieris Pharmaceuticals, Inc. | 21.20M | 3.49% | 8,008 | 1.35M |
| 515 | COCP | Cocrystal Pharma, Inc. | 20.96M | - | 11,701 | - |
| 516 | ENLV | Enlivex Therapeutics Ltd. | 20.89M | -5.24% | 388,102 | - |
| 517 | NRBO | NeuroBo Pharmaceuticals, Inc. | 20.68M | -2.04% | 21,633 | - |
| 518 | PULM | Pulmatrix, Inc. | 20.53M | 3.50% | 244,611 | 10.01M |
| 519 | XCUR | Exicure, Inc. | 20.51M | 92.27% | 22,842,607 | 500.00K |
| 520 | SPRB | Spruce Biosciences, Inc. | 20.24M | 0.89% | 172,350 | 7.10M |
| 521 | PMN | ProMIS Neurosciences, Inc. | 20.07M | -2.24% | 41,054 | - |
| 522 | IBIO | iBio, Inc. | 20.04M | -1.79% | 66,323 | 175.00K |
| 523 | FBRX | Forte Biosciences, Inc. | 19.79M | 143.71% | 29,415,905 | - |
| 524 | UBX | Unity Biotechnology, Inc. | 19.71M | 0.86% | 52,827 | - |
| 525 | NRSN | NeuroSense Therapeutics Ltd. | 19.28M | -11.20% | 192,987 | - |
| 526 | KAPA | Kairos Pharma, Ltd. | 18.75M | -0.68% | 84,874 | - |
| 527 | MEIP | MEI Pharma, Inc. | 18.66M | -2.10% | 30,212 | - |
| 528 | PTN | Palatin Technologies, Inc. | 17.79M | -2.15% | 172,260 | 2.38M |
| 529 | CGTX | Cognition Therapeutics, Inc. | 17.66M | -0.90% | 853,349 | - |
| 530 | AKTX | Akari Therapeutics, Plc | 17.57M | -8.70% | 96,686 | - |
| 531 | MRNS | Marinus Pharmaceuticals, Inc. | 17.02M | 0.49% | 649,026 | 31.47M |
| 532 | SYBX | Synlogic, Inc. | 16.90M | 6.24% | 2,177 | 2.78M |
| 533 | CARA | Cara Therapeutics, Inc. | 16.73M | 1.36% | 205,096 | 8.69M |
| 534 | KZIA | Kazia Therapeutics Limited | 16.71M | -0.36% | 41,004 | 1.66M |
| 535 | APLM | Apollomics, Inc. | 16.52M | -8.83% | 9,483,967 | 2.10M |
| 536 | APRE | Aprea Therapeutics, Inc. | 16.36M | -0.33% | 12,021 | 1.31M |
| 537 | TENX | Tenax Therapeutics, Inc. | 16.26M | -1.85% | 15,007 | - |
| 538 | NNVC | NanoViricides, Inc. | 15.71M | -2.92% | 102,523 | - |
| 539 | NERV | Minerva Neurosciences, Inc. | 14.83M | 0.95% | 3,898 | - |
| 540 | CANF | Can-Fite BioPharma Ltd. | 14.75M | -0.99% | 95,514 | 667.00K |
| 541 | CING | Cingulate Inc. | 14.39M | 9.27% | 394,116 | - |
| 542 | TRAW | Traws Pharma, Inc. | 13.58M | -4.67% | 9,788 | 226.00K |
| 543 | PMCB | PharmaCyte Biotech, Inc. | 13.21M | -7.03% | 6,677 | - |
| 544 | NRXP | NRx Pharmaceuticals, Inc. | 12.93M | -1.22% | 68,548 | - |
| 545 | ENSC | Ensysce Biosciences, Inc. | 12.83M | -3.26% | 1,153,079 | 4.42M |
| 546 | AIM | AIM ImmunoTech Inc. | 12.66M | 11.11% | 1,002,616 | 190.00K |
| 547 | SNSE | Sensei Biotherapeutics, Inc. | 12.53M | 3.77% | 439,311 | - |
| 548 | SLGL | Sol-Gel Technologies Ltd. | 12.29M | 2.53% | 51,932 | 11.71M |
| 549 | LYRA | Lyra Therapeutics, Inc. | 11.65M | -9.04% | 6,638,137 | 1.47M |
| 550 | NKGN | NKGen Biotech, Inc. | 11.27M | 7.97% | 376,335 | - |
| 551 | IMRN | Immuron Limited | 11.21M | -2.15% | 2,291 | 3.27M |
| 552 | IPA | ImmunoPrecise Antibodies Ltd. | 11.13M | -5.42% | 165,320 | 17.44M |
| 553 | INDP | Indaptus Therapeutics, Inc. | 10.81M | 2.91% | 11,587 | - |
| 554 | TSBX | Turnstone Biologics Corp. | 10.64M | -2.36% | 140,818 | - |
| 555 | VCNX | Vaccinex, Inc. | 10.37M | 12.08% | 29,208 | 388.00K |
| 556 | ATHE | Alterity Therapeutics Limited | 10.36M | -6.25% | 16,869 | 2.68M |
| 557 | KPRX | Kiora Pharmaceuticals, Inc. | 10.16M | 5.88% | 15,942 | 16.02M |
| 558 | IMNN | Imunon, Inc. | 9.92M | -1.01% | 241,959 | - |
| 559 | DOMH | Dominari Holdings Inc. | 9.85M | -3.68% | 41,103 | 12.59M |
| 560 | SNTI | Senti Biosciences, Inc. | 9.71M | -2.75% | 6,636 | - |
| 561 | BRTX | BioRestorative Therapies, Inc. | 9.69M | 4.48% | 8,664 | 377.00K |
| 562 | CDT | Conduit Pharmaceuticals Inc. | 9.49M | 0.22% | 4,836,064 | - |
| 563 | ICU | SeaStar Medical Holding Corporation | 9.38M | 1.42% | 90,077 | 68.00K |
| 564 | CSCI | COSCIENS Biopharma Inc. | 9.34M | -0.64% | 7,140 | 4.83M |
| 565 | VINC | Vincerx Pharma, Inc. | 9.25M | 0.99% | 204,605 | - |
| 566 | EVGN | Evogene Ltd. | 9.21M | -4.35% | 98,188 | 9.45M |
| 567 | PHGE | BiomX Inc. | 9.11M | -12.24% | 103,655 | - |
| 568 | JAGX | Jaguar Health, Inc. | 9.06M | 1.07% | 143,647 | 10.48M |
| 569 | ONCO | Onconetix, Inc. | 8.96M | -5.26% | 86,567 | 1.46M |
| 570 | SNGX | Soligenix, Inc. | 8.81M | -0.57% | 22,358 | 364.18K |
| 571 | VRAX | Virax Biolabs Group Limited | 8.16M | -2.08% | 112,605 | 84.87K |
| 572 | EYEN | Eyenovia, Inc. | 7.99M | -22.48% | 27,671,839 | 31.83K |
| 573 | EVAX | Evaxion Biotech A/S | 7.81M | -9.09% | 46,191 | 3.30M |
| 574 | SYRS | Syros Pharmaceuticals, Inc. | 7.77M | 4.77% | 16,003,732 | 386.00K |
| 575 | MBIO | Mustang Bio, Inc. | 7.77M | -5.30% | 392,402 | - |
| 576 | COEP | Coeptis Therapeutics Holdings, Inc. | 7.69M | -0.51% | 76,646 | - |
| 577 | GLTO | Galecto, Inc. | 7.65M | -1.53% | 2,927 | - |
| 578 | MBRX | Moleculin Biotech, Inc. | 7.59M | 1.14% | 33,278 | - |
| 579 | CDIO | Cardio Diagnostics Holdings, Inc. | 7.47M | -6.04% | 1,080,560 | 35.69K |
| 580 | KLTO | Klotho Neurosciences, Inc. | 7.23M | -2.27% | 74,677 | - |
| 581 | EDSA | Edesa Biotech, Inc. | 7.14M | 0.46% | 10,612 | - |
| 582 | GTBP | GT Biopharma, Inc. | 7.13M | 5.98% | 15,502 | - |
| 583 | PSTV | Plus Therapeutics, Inc. | 7.02M | -2.46% | 15,240 | 5.73M |
| 584 | BCDA | BioCardia, Inc. | 6.97M | -1.97% | 47,364 | 71.00K |
| 585 | ABVC | ABVC BioPharma, Inc. | 6.80M | 8.04% | 27,888 | 509.79K |
| 586 | BCLI | Brainstorm Cell Therapeutics Inc. | 6.70M | 0.80% | 40,356 | - |
| 587 | ADXN | Addex Therapeutics Ltd | 6.64M | -7.40% | 10,931 | 960.64K |
| 588 | ADIL | Adial Pharmaceuticals, Inc. | 6.53M | 0.99% | 96,596 | - |
| 589 | APTO | Aptose Biosciences Inc. | 6.49M | -23.97% | 1,027,030 | - |
| 590 | NLSP | NLS Pharmaceutics AG | 6.24M | 3.46% | 66,232 | - |
| 591 | XBIO | Xenetic Biosciences, Inc. | 6.15M | 5.00% | 4,921 | 2.52M |
| 592 | CNSP | CNS Pharmaceuticals, Inc. | 6.13M | -2.52% | 7,809,562 | - |
| 593 | VIRX | Viracta Therapeutics, Inc. | 5.99M | -0.72% | 382,721 | - |
| 594 | BIOR | Biora Therapeutics, Inc. | 5.96M | -0.61% | 222,935 | 892.00K |
| 595 | ALZN | Alzamend Neuro, Inc. | 5.86M | -6.43% | 117,280 | - |
| 596 | RNAZ | TransCode Therapeutics, Inc. | 5.80M | 2.50% | 202,682 | - |
| 597 | HOTH | Hoth Therapeutics, Inc. | 5.71M | 1.05% | 8,978,167 | - |
| 598 | CMND | Clearmind Medicine Inc. | 5.52M | 1.49% | 71,913 | - |
| 599 | ONVO | Organovo Holdings, Inc. | 5.38M | 2.58% | 581,222 | 103.00K |
| 600 | APVO | Aptevo Therapeutics Inc. | 5.37M | 16.05% | 12,728,413 | - |
| 601 | CYCN | Cyclerion Therapeutics, Inc. | 5.26M | 18.75% | 136,364 | 194.00K |
| 602 | PPBT | Purple Biotech Ltd | 5.08M | -4.26% | 62,454 | - |
| 603 | BNOX | Bionomics Limited | 4.89M | -5.05% | 1,136,985 | - |
| 604 | PRTG | Portage Biotech Inc. | 4.79M | 10.12% | 81,454 | - |
| 605 | WINT | Windtree Therapeutics, Inc. | 4.46M | 9.13% | 861,838 | - |
| 606 | GLMD | Galmed Pharmaceuticals Ltd. | 4.46M | -1.33% | 49,468 | - |
| 607 | CELZ | Creative Medical Technology Holdings, Inc. | 4.46M | 1.19% | 26,489 | 11.00K |
| 608 | XRTX | XORTX Therapeutics Inc. | 4.36M | -6.67% | 12,840 | - |
| 609 | SILO | Silo Pharma, Inc. | 4.24M | -2.56% | 128,313 | 72.10K |
| 610 | KTTA | Pasithea Therapeutics Corp. | 4.04M | 1.27% | 743,872 | - |
| 611 | APM | Aptorum Group Limited | 4.03M | -1.22% | 63,830 | 431.38K |
| 612 | HEPA | Hepion Pharmaceuticals, Inc. | 4.03M | 3.63% | 40,295 | - |
| 613 | GNPX | Genprex, Inc. | 3.96M | -14.40% | 961,335 | - |
| 614 | CHRO | Chromocell Therapeutics Corporation | 3.73M | 14.42% | 51,705 | - |
| 615 | THAR | Tharimmune, Inc. | 3.72M | 2.88% | 172,902 | - |
| 616 | ARTL | Artelo Biosciences, Inc. | 3.71M | 4.55% | 16,208 | - |
| 617 | SNPX | Synaptogenix, Inc. | 3.59M | 7.76% | 10,387 | - |
| 618 | AZTR | Azitra, Inc. | 3.58M | 1.08% | 52,469 | 97.50K |
| 619 | OGEN | Oragenics, Inc. | 3.52M | 2.86% | 174,019 | - |
| 620 | NBY | NovaBay Pharmaceuticals, Inc. | 3.46M | 1.29% | 31,322 | 13.84M |
| 621 | TCRT | Alaunos Therapeutics, Inc. | 3.41M | 0.47% | 13,403 | 7.00K |
| 622 | TNFA | TNF Pharmaceuticals, Inc. | 3.39M | 7.89% | 64,379 | - |
| 623 | ONCT | Oncternal Therapeutics, Inc. | 3.37M | 5.56% | 26,303 | 2.16M |
| 624 | LIXT | Lixte Biotechnology Holdings, Inc. | 3.35M | -2.61% | 20,023 | - |
| 625 | TTNP | Titan Pharmaceuticals, Inc. | 3.34M | 1.11% | 14,957 | 3.00K |
| 626 | PALI | Palisade Bio, Inc. | 3.24M | 0.41% | 255,178 | - |
| 627 | DWTX | Dogwood Therapeutics, Inc. | 3.24M | -6.18% | 75,364 | - |
| 628 | QNRX | Quoin Pharmaceuticals, Ltd. | 3.16M | -1.17% | 51,026 | - |
| 629 | ENVB | Enveric Biosciences, Inc. | 3.12M | -1.44% | 54,770 | - |
| 630 | VRPX | Virpax Pharmaceuticals, Inc. | 3.02M | -6.56% | 275,389 | - |
| 631 | PCSA | Processa Pharmaceuticals, Inc. | 2.96M | 1.34% | 10,323 | - |
| 632 | ADTX | Aditxt, Inc. | 2.96M | -3.17% | 655,734 | 212.11K |
| 633 | BPTH | Bio-Path Holdings, Inc. | 2.92M | -1.41% | 14,083 | - |
| 634 | LIPO | Lipella Pharmaceuticals Inc. | 2.91M | -3.21% | 44,655 | 483.53K |
| 635 | ATXI | Avenue Therapeutics, Inc. | 2.88M | 2.03% | 19,239 | - |
| 636 | NCNA | NuCana plc | 2.88M | -3.76% | 69,618 | - |
| 637 | TOVX | Theriva Biologics, Inc. | 2.86M | - | 57,395 | - |
| 638 | INM | InMed Pharmaceuticals Inc. | 2.82M | -2.76% | 20,648 | 4.96M |
| 639 | SLXN | Silexion Therapeutics Corp | 2.77M | 45.33% | 199,238,828 | - |
| 640 | MTNB | Matinas BioPharma Holdings, Inc. | 2.71M | -4.42% | 65,994 | - |
| 641 | FRES | Fresh2 Group Limited | 2.69M | 7.08% | 15,108 | 2.34M |
| 642 | PTIX | Protagenic Therapeutics, Inc. | 2.66M | 2.44% | 40,325 | - |
| 643 | CYCC | Cyclacel Pharmaceuticals, Inc. | 2.58M | -0.62% | 290,309 | 74.00K |
| 644 | MTEM | Molecular Templates, Inc. | 2.55M | -3.89% | 805,755 | 25.47M |
| 645 | SCNI | Scinai Immunotherapeutics Ltd. | 2.46M | 5.21% | 15,179 | 284.00K |
| 646 | ATNF | 180 Life Sciences Corp. | 2.40M | -0.43% | 38,060 | - |
| 647 | BDRX | Biodexa Pharmaceuticals Plc | 2.24M | 7.84% | 33,020 | 104.90K |
| 648 | QLGN | Qualigen Therapeutics, Inc. | 2.09M | 0.26% | 40,227 | - |
| 649 | SCPX | Scorpius Holdings, Inc. | 2.07M | 0.76% | 67,152 | 10.04M |
| 650 | PHIO | Phio Pharmaceuticals Corp. | 2.05M | -6.67% | 34,203 | - |
| 651 | SLRX | Salarius Pharmaceuticals, Inc. | 2.02M | -0.71% | 44,199 | - |
| 652 | SONN | Sonnet BioTherapeutics Holdings, Inc. | 1.90M | -3.95% | 110,339 | 55.88K |
| 653 | GRI | GRI Bio, Inc. | 1.87M | -6.76% | 265,708 | - |
| 654 | DRMA | Dermata Therapeutics, Inc. | 1.75M | 6.42% | 544,373 | - |
| 655 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 1.71M | 0.01% | 13,036 | 462.61K |
| 656 | ALLR | Allarity Therapeutics, Inc. | 1.68M | -4.80% | 408,158 | - |
| 657 | CYTO | Altamira Therapeutics Ltd. | 1.50M | -0.02% | 36,336 | - |
| 658 | ENTO | Entero Therapeutics, Inc. | 1.30M | -1.74% | 85,634 | - |
| 659 | TFFP | TFF Pharmaceuticals, Inc. | 1.29M | -5.94% | 3,309,666 | 1.16M |
| 660 | REVB | Revelation Biosciences, Inc. | 1.25M | -2.46% | 204,522 | - |
| 661 | ZVSA | ZyVersa Therapeutics, Inc. | 1.24M | -6.50% | 2,667,386 | - |
| 662 | ELAB | Elevai Labs Inc. | 1.06M | 0.47% | 188,900,242 | 2.45M |
| 663 | SPRC | SciSparc Ltd. | 853.85K | 0.42% | 49,922 | 1.75M |
| 664 | PBM | Psyence Biomedical Ltd. | 834.83K | -4.76% | 32,787,481 | - |
| 665 | TCBP | TC Biopharm (Holdings) Plc | 345.28K | 5.83% | 628,624 | - |